Sera of patients with prostatic malignancy were assayed for human chorionic gonadotropin-beta (HCG-beta). The levels of HCB-beta are negligible in the patients and in a control group with benign prostatic hypertrophy. Slight increases in HCG-beta found in a small percentage of patients with advanced malignancy are attributed to cross-reacting gonadotropins.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000280334 | DOI Listing |
Publication Analysis
Top Keywords
human chorionic
8
chorionic gonadotropin-beta
8
evaluation human
4
gonadotropin-beta levels
4
levels prostatic
4
prostatic carcinoma
4
carcinoma sera
4
sera patients
4
patients prostatic
4
prostatic malignancy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!